A detailed history of Ethic Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ethic Inc. holds 44,376 shares of TEVA stock, worth $759,273. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,376
Previous 39,979 11.0%
Holding current value
$759,273
Previous $564,000 27.84%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.78 - $17.4 $56,193 - $76,507
4,397 Added 11.0%
44,376 $721,000
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $306,741 - $414,833
28,748 Added 255.97%
39,979 $564,000
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $1,429 - $1,870
-176 Reduced 1.54%
11,231 $117,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $85,324 - $122,054
11,407 New
11,407 $116,000
Q1 2023

May 12, 2023

BUY
$8.36 - $11.37 $120,768 - $164,251
14,446 New
14,446 $127,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $91,869 - $160,034
13,392 New
13,392 $108,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.